Concepedia

Gus Khursigara

GK

Statistics

Publications

15

Citations

2.4K

H-Index

15

Active since

1994

Affiliations

Alexion Pharmaceuticals (United States)(Current)

New York University

St James's University Hospital

Alexion Pharma (Switzerland)

National Human Genome Research Institute

Gus Khursigara is an author at Alexion Pharmaceuticals (United States) specializing in medicine, clinical pharmacology, and paroxysmal nocturnal hemoglobinuria therapy.

ORCID

Publications per year

1994–2021

15

Publications

15

Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1

Albert H. Kim, Gus Khursigara, Xuan Sun et al. · Molecular and Cellular Biology · 2001 · 713 citations · Full text

, , +13

Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Hubert Schrezenmeier, Petra Muus, G. Socié et al. · Haematologica · 2014 · 266 citations · Full text

, , +16

Association of the p75 Neurotrophin Receptor with TRAF6

Gus Khursigara, Jason R. Orlinick, Moses V. Chao · Journal of Biological Chemistry · 1999 · 239 citations · Full text

, , +15

Transformation of Lupus-Inducing Drugs to Cytotoxic Products by Activated Neutrophils

Xiaoxia Jiang, Gus Khursigara, Robert L. Rubin · Science · 1994 · 238 citations

, , +17

Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen, Modupe Elebute, Richard J. Kelly et al. · American Journal of Hematology · 2010 · 205 citations

, , +15

1–5 of 15